Sara Gasparrini

Landscape of somatic single-nucleotide and copy-number mutations in uterine serous carcinoma

Siming Zhao, Murim Choi, John D. Overton et al. · Proceedings of the National Academy of Sciences · 2013 · 337 citations · Full text

Medicine, Genetics, Oncology +17

Downregulation of membrane complement inhibitors CD55 and CD59 by siRNA sensitises uterine serous carcinoma overexpressing Her2/neu to complement and antibody-dependent cell cytotoxicity in vitro: implications for trastuzumab-based immunotherapy

Stefania Bellone, Dana M. Roque, Emiliano Cocco et al. · British Journal of Cancer · 2012 · 60 citations · Full text

Life Sciences, Cancer Biology, Oncology +17

Tubulin‐β‐III overexpression by uterine serous carcinomas is a marker for poor overall survival after platinum/taxane chemotherapy and sensitivity to epothilones

Dana M. Roque, Stefania Bellone, Diana P. English et al. · Cancer · 2013 · 55 citations · Full text

Medicine, Oncology, Pharmacology +16

Class III β-tubulin overexpression within the tumor microenvironment is a prognostic biomarker for poor overall survival in ovarian cancer patients treated with neoadjuvant carboplatin/paclitaxel

Dana M. Roque, Natália Buza, Michelle Glasgow et al. · Clinical & Experimental Metastasis · 2013 · 52 citations · Full text

Medicine, Cancer Biology, Oncology +17

Uterine and ovarian carcinosarcomas overexpressing Trop-2 are sensitive to hRS7, a humanized anti-Trop-2 antibody

Rhoda Raji, Federica Guzzo, Luisa Carrara et al. · Journal of Experimental & Clinical Cancer Research · 2011 · 48 citations · Full text

Medicine, Cancer Biology, Oncology +17